WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Earnings & Revenue

ABOS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$55.9M
Current Profit Margin
0%

ABOS Return on Equity

Current Company
-22.9%
Current Industry
16.9%
Current Market
28.2%
ABOS's Return on Equity (-22.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABOS announces earnings.

ABOS Return on Assets

Current Company
-20.8%
Current Industry
3.2%
ABOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABOS Return on Capital Employed

Current Company
-18.58%
Current Industry
-42.5%
ABOS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABOS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABOS$0.00-$54.18M-$55.94MN/AN/A
DRTS$0.00-$21.53M-$29.16MN/AN/A
IVA$25.18M-$109.06M-$120.03M+24.86%N/A
ZURA$0.00-$58.52M-$60.18MN/AN/A
TELON/AN/AN/AN/AN/A

ABOS earnings dates

Next earnings date
Aug 8, 2024

Acumen Pharmaceuticals Earnings & Revenue FAQ

What were ABOS's earnings last quarter?

On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q1 2024 earnings per share (EPS) of -$0.25, up 10.71% year over year. Total Acumen Pharmaceuticals earnings for the quarter were -$14.87 million. In the same quarter last year, Acumen Pharmaceuticals's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.

What was ABOS's earnings growth in the past year?

As of Q2 2024, Acumen Pharmaceuticals's earnings has grown year over year. Acumen Pharmaceuticals's earnings in the past year totalled -$55.94 million.

What is ABOS's earnings date?

Acumen Pharmaceuticals's earnings date is Invalid Date. Add ABOS to your watchlist to be reminded of ABOS's next earnings announcement.

What was ABOS's revenue last quarter?

On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Acumen Pharmaceuticals's revenue was $0.00.

What was ABOS's revenue growth in the past year?

As of Q2 2024, Acumen Pharmaceuticals's revenue has grown null year over year. Acumen Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.